Stemcell technologies INC:1109892 [18-005049]
Ended Purchase Order Awarded Last action
- Contract number
- HHSN269201800212P
- Awardee
-
Stemcell Technologies Inc. UEI ELPMWCGFK518
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Obligated
- $4,356
Award facts
- Contract value 100% obligated
- $4,356.00 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Burien, WA 98168, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$25 | |
| Original award | $4,381 |
About this award
This federal contract award, valued at $4,356.00, was made by the National Institutes of Health (NIH) to Stemcell Technologies Inc., a subsidiary of the Canadian company Stemcell Technologies. The contract is a Firm Fixed Price Purchase Order that runs through October 18, 2024. Stemcell Technologies Inc. is not a small business set-aside, but the company has been awarded some small business set-aside contracts in the past, indicating flexibility in its contracting status.
Stemcell Technologies Inc. is a key supplier of specialized biological materials, laboratory supplies, scientific equipment, and proprietary products to support biomedical research initiatives across various U.S. government agencies, particularly within the Department of Health and Human Services. The company holds a significant Indefinite Delivery Vehicle (IDV) in the form of a single-award Blanket Purchase Agreement (BPA) with the NIH Office of Logistics and Acquisition Operations, valued at up to $10,000,000 and running through December 31, 2024. This BPA allows for streamlined procurement of commonly used research materials across various NIH institutes and centers, underscoring Stemcell Technologies Inc.'s important role as a preferred supplier to the federal biomedical research community.
Quick answers
Who was awarded contract HHSN269201800212P?
HHSN269201800212P was awarded to Stemcell Technologies Inc. by NIH Clinical Center (National Institutes of Health) on January 24, 2018.
How much is contract HHSN269201800212P worth?
The government has obligated $4,356 on HHSN269201800212P.
Was contract HHSN269201800212P competed?
The extent of competition for HHSN269201800212P was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award